EUVIMEDEUVIMED entdecken
Open Access

Large‐Scale Proteomics Uncovers Pre‐Disease Inflammation–Lipid Subtypes to Refine Risk Stratification and Prediction of Type 2 Diabetes

Qiu Xiao, Yi Zheng, Hanhan Zhao, Yucan Li, Jianwei Wang, Hao Wang, Chen Suo, Yanfeng Jiang, Xingdong Chen, Kelin Xu iD

Diabetes, Obesity and Metabolism · 2026

DOI: 10.1111/dom.71038 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Qiu Xiao und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, and the Key Laboratory of Public Health Safety of Ministry of Education, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Proteomics, Inflammation, Prediabetic State. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, Brain Science and Brain-like Intelligence Technology-National Science and Technology Major Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Type 2 diabetes exhibits substantial heterogeneity prior to disease onset, posing challenges for early prevention. This study aimed to identify pre‐disease subgroups with distinct risk profiles and develop subgroup‐specific prediction models to facilitate early detection and precision intervention. Materials and Methods Proteomic data from 41 030 participants without diabetes at baseline in the UK Biobank were analysed. Proteins associated with incident type 2 diabetes were identified using multivariable‐adjusted Cox regression and Least Absolute Shrinkage and Selection Operator (LASSO) regression. Finite Gaussian mixture model–based clustering was applied to define risk subgroups. Heterogeneity among subgroups was characterised according to proteomic patterns, clinical traits and disease risk. Subgroup‐specific prediction models were subsequently developed using Cox regression.

Results

A total of 113 protein markers were identified, stratifying the population into three subgroups: metabolically healthy group (MHG), mild inflammation group (MIG) and Dyslipidemia with inflammation group (DLIG). Compared with MHG, DLIG showed the highest risk of type 2 diabetes (HR = 2.58, 95% CI: 2.34–2.84), followed by MIG (HR = 1.71, 95% CI: 1.49–1.98). Enrichment analysis indicated dysregulation of immune–inflammatory and lipid metabolism pathways in DLIG and MIG. Clinically, DLIG exhibited higher BMI, waist circumference, triglycerides, and C‐reactive protein levels, whereas MIG showed moderately elevated C‐reactive protein. Subgroup‐specific proteomic models outperformed traditional clinical models in predicting diabetes risk (AUC 0.820–0.889 vs. 0.709–0.784; C‐index 0.787–0.847 vs. 0.687–0.747).

Conclusion

Proteomics‐based clustering identified three pre‐disease subtypes of type 2 diabetes characterized by inflammation–lipid profiles, improving risk prediction and supporting precision prevention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2ProteomicsInflammationPrediabetic StateLipidsHumansFemaleMaleMiddle AgedRisk AssessmentBiomarkersRisk FactorsDyslipidemiasUK BiobankUnited KingdomAged

Stichwörter der Autor:innen

cohort studyprediction modelsproteomicsrisk subgroupstype 2 diabetes

Substanzen

BiomarkersLipids

Autor:innen und Institutionen

  • School of Public Health, and the Key Laboratory of Public Health Safety of Ministry of Education, Fudan University, Shanghai, China.
  • State Key Laboratory of Genetics and Development of Complex Phenotypes, Human Phenome Institute, Zhangjiang Fudan International Innovation Center, Fudan University, Shanghai, China.
  • Fudan University Taizhou Institute of Health Sciences, Taizhou, Jiangsu, China.
  • National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China.
  • Yiwu Research Institute of Fudan University, Yiwu, Zhejiang, China.

ORCID-Profile: Kelin Xu

Förderung

  • National Natural Science Foundation of China
  • National Key R&D Program of China
  • Brain Science and Brain-like Intelligence Technology-National Science and Technology Major Project
  • National Key Research and Development Program of China

Zitieren

APA

Xiao, Q., Zheng, Y., Zhao, H., Li, Y., Wang, J., Wang, H., Suo, C., Jiang, Y., Chen, X., & Xu, K. (2026). Large‐Scale Proteomics Uncovers Pre‐Disease Inflammation–Lipid Subtypes to Refine Risk Stratification and Prediction of Type 2 Diabetes. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.71038

Vancouver

Xiao Q, Zheng Y, Zhao H, Li Y, Wang J, Wang H, et al. Large‐Scale Proteomics Uncovers Pre‐Disease Inflammation–Lipid Subtypes to Refine Risk Stratification and Prediction of Type 2 Diabetes. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.71038

BibTeX
@article{Xiao2026,
  author = {Xiao, Qiu and Zheng, Yi and Zhao, Hanhan and Li, Yucan and Wang, Jianwei and Wang, Hao and Suo, Chen and Jiang, Yanfeng and Chen, Xingdong and Xu, Kelin},
  title = {Large‐Scale Proteomics Uncovers Pre‐Disease Inflammation–Lipid Subtypes to Refine Risk Stratification and Prediction of Type 2 Diabetes},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  doi = {10.1111/dom.71038}
}
Kostenlos starten →